BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29278971)

  • 1. Prevention Strategies Against HIV Transmission: A Proactive Approach.
    Carrion AJ; Miles JD; Mosley JF; Smith LL; Prather AS; Gurley MM; Phan LD; Everton EC
    J Pharm Pract; 2018 Feb; 31(1):82-90. PubMed ID: 29278971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
    Heendeniya A; Bogoch II
    Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.
    Tan DHS; Hull MW; Yoong D; Tremblay C; O'Byrne P; Thomas R; Kille J; Baril JG; Cox J; Giguere P; Harris M; Hughes C; MacPherson P; O'Donnell S; Reimer J; Singh A; Barrett L; Bogoch I; Jollimore J; Lambert G; Lebouche B; Metz G; Rogers T; Shafran S;
    CMAJ; 2017 Nov; 189(47):E1448-E1458. PubMed ID: 29180384
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.
    Kalapila AG; Marrazzo J
    Med Clin North Am; 2016 Jul; 100(4):927-50. PubMed ID: 27235622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review.
    Elliott T; Sanders EJ; Doherty M; Ndung'u T; Cohen M; Patel P; Cairns G; Rutstein SE; Ananworanich J; Brown C; Fidler S
    J Int AIDS Soc; 2019 Dec; 22(12):e25419. PubMed ID: 31850686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis.
    Krakower DS; Jain S; Mayer KH
    Curr HIV/AIDS Rep; 2015 Mar; 12(1):127-38. PubMed ID: 25600106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical update.
    Haddow L; Herbert S
    Sex Transm Infect; 2015 Mar; 91(2):150. PubMed ID: 25698792
    [No Abstract]   [Full Text] [Related]  

  • 8. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019.
    Harvala H; Reynolds C; Ijaz S; Maddox V; Penchala SD; Amara A; Else L; Brailsford S; Khoo S
    Sex Transm Infect; 2022 Mar; 98(2):132-135. PubMed ID: 33782147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoprevention of Human Immunodeficiency Virus Infection.
    Yingling C; Broholm C; Stephenson S
    Nurs Clin North Am; 2020 Sep; 55(3):429-444. PubMed ID: 32762861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrEP: why are we waiting?
    Lancet HIV
    Lancet HIV; 2015 Oct; 2(10):e401. PubMed ID: 26423641
    [No Abstract]   [Full Text] [Related]  

  • 12. The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda.
    Baggaley R; Doherty M; Ball A; Ford N; Hirnschall G
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S159-60. PubMed ID: 25972496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016.
    Moreno S; Antela A; García F; Del Amo J; Boix V; Coll P; Fortuny C; Sirvent JLG; Gutiérrez F; Iribarren JA; Llibre JM; Quirós JCLB; Losa JE; Lozano A; Meulbroek M; Olalla J; Pujol F; Pulido F; Crespo Casal M; García JG; Aldeguer JL; Molina JAP; Podzamczer Palter D; Román AR;
    Enferm Infecc Microbiol Clin; 2017; 35(6):377-383. PubMed ID: 28236498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of the use of oral medication to prevent HIV transmission.
    Mayer KH; Ramjee G
    Curr Opin HIV AIDS; 2015 Jul; 10(4):226-32. PubMed ID: 26049946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods and Approaches to HIV Prevention.
    Balthazar MS
    J Assoc Nurses AIDS Care; 2017; 28(1):19-24. PubMed ID: 27751633
    [No Abstract]   [Full Text] [Related]  

  • 16. Promise and pitfalls of pre-exposure prophylaxis for female sex workers.
    Cowan FM; Delany-Moretlwe S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):27-34. PubMed ID: 26633639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregnancy: a model of prevention of HIV transmission].
    Mandelbrot L
    Bull Acad Natl Med; 2014; 198(4-5):813-24. PubMed ID: 26753411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrEP: why we are waiting.
    Jansen MP; Tromp N; Baltussen R
    Lancet HIV; 2016 Jan; 3(1):e11-2. PubMed ID: 26762986
    [No Abstract]   [Full Text] [Related]  

  • 19. Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
    Tetteh RA; Yankey BA; Nartey ET; Lartey M; Leufkens HG; Dodoo AN
    Drug Saf; 2017 Apr; 40(4):273-283. PubMed ID: 28130774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Pre-Exposure Prophylaxis and Postexposure Prophylaxis in Japan: Context of Use and Directions for Future Research and Action.
    DiStefano AS; Takeda M
    AIDS Patient Care STDS; 2017 Feb; 31(2):60-77. PubMed ID: 28170304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.